Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance
Abstract Most cancer-related deaths result from drug-resistant disease(1,2). However, cancer drug resistance is not a primary focus in drug development. Effectively mitigating and treating drug-resistant cancer will require advancements in multiple fields, including early detection, drug discovery,...
Saved in:
| Main Authors: | James Ingham, Jia-Ling Ruan, Matthew A. Coelho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00129-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community nudges: why we need tools for turning on the we-mode to tackle problems that concern all of us
by: Denise de Ridder
Published: (2025-06-01) -
The Unique Capability of Endolysin to Tackle Antibiotic Resistance: Cracking the Barrier
by: Abdus Sabur, et al.
Published: (2025-01-01) -
One Health approaches to tackling antimicrobial resistance
by: M.E.J. Woolhouse
Published: (2024-01-01) -
Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.
by: Magnus Unemo, et al.
Published: (2017-10-01) -
Boron-Containing Compounds as Antimicrobial Agents to Tackle Drug-Resistant Bacteria
by: Zongkai Huang, et al.
Published: (2024-12-01)